Connection

STEPHEN YENZEN LAI to STAT3 Transcription Factor

This is a "connection" page, showing publications STEPHEN YENZEN LAI has written about STAT3 Transcription Factor.
  1. Targeting STAT3 inhibits growth and enhances radiosensitivity in head and neck squamous cell carcinoma. Oral Oncol. 2012 Dec; 48(12):1220-6.
    View in: PubMed
    Score: 0.256
  2. Small-molecule inhibition of STAT3 in radioresistant head and neck squamous cell carcinoma. Oncotarget. 2016 May 03; 7(18):26307-30.
    View in: PubMed
    Score: 0.083
  3. STAT5A-mediated SOCS2 expression regulates Jak2 and STAT3 activity following c-Src inhibition in head and neck squamous carcinoma. Clin Cancer Res. 2012 Jan 01; 18(1):127-39.
    View in: PubMed
    Score: 0.061
  4. Epidermal growth factor receptor variant III mediates head and neck cancer cell invasion via STAT3 activation. Oncogene. 2010 Sep 16; 29(37):5135-45.
    View in: PubMed
    Score: 0.056
  5. Intratumoral epidermal growth factor receptor antisense DNA therapy in head and neck cancer: first human application and potential antitumor mechanisms. J Clin Oncol. 2009 Mar 10; 27(8):1235-42.
    View in: PubMed
    Score: 0.051
  6. Heteromerization of the gammac chain with the interleukin-9 receptor alpha subunit leads to STAT activation and prevention of apoptosis. J Biol Chem. 1998 Apr 10; 273(15):9255-60.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.